{"denomUnitsSelected":"Participants","description":"We will use the Kaplan-Meier method to estimate event-free survival. We define EFS as the time elapsed from protocol enrollment to death, relapse, discontinuation of therapy due to excessive toxicity or resistant disease, or development of an additional malignancy and censor times for patients free of these events at last follow-up.","reportingStatus":"NOT_POSTED","timeFrame":"3 years from study entry","title":"Event-free Survival (EFS) of Patients Who Received One or Two Courses of CPX-351 Followed by HSCT","type":"SECONDARY"}